For: | Arias-Loste MT, García-Unzueta MT, Llerena S, Iruzubieta P, Puente A, Cabezas J, Alonso C, Cuadrado A, Amado JA, Crespo J, Fábrega E. Plasma betatrophin levels in patients with liver cirrhosis. World J Gastroenterol 2015; 21(37): 10662-10668 [PMID: 26457026 DOI: 10.3748/wjg.v21.i37.10662] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i37/10662.htm |
Number | Citing Articles |
1 |
A. F. H. Pfeiffer. Hepatogener Diabetes. Der Diabetologe 2016; 12(7): 468 doi: 10.1007/s11428-016-0141-2
|
2 |
Shuang Liu, Rui Li, Ya-Wen Sun, Hai Lin, Hai-Fang Li. Protein succinylation, hepatic metabolism, and liver diseases. World Journal of Hepatology 2024; 16(3): 344-352 doi: 10.4254/wjh.v16.i3.344
|
3 |
Laure Elkrief, Pierre‐Emmanuel Rautou, Shiv Sarin, Dominique Valla, Valérie Paradis, Richard Moreau. Diabetes mellitus in patients with cirrhosis: clinical implications and management. Liver International 2016; 36(7): 936 doi: 10.1111/liv.13115
|
4 |
Fereshteh Pashayee-khamene, Behzad Hatami, Makan Cheraghpour, Zahra Yari. Keeping an eye on the nutrition: The importance of nutrition management on cardiometabolic risk factors in cirrhotic patients. Clinical Nutrition ESPEN 2023; 58: 186 doi: 10.1016/j.clnesp.2023.09.927
|
5 |
Wen Hu, Xiaojuan Shao, Dianxuan Guo, Hairong Hao, Yong Zhang, Mingfeng Xia, Yingyun Gong, Hongwen Zhou, Yunqing Fan, Weinan Yu, Vincent Wong. Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population. PLOS ONE 2017; 12(1): e0170758 doi: 10.1371/journal.pone.0170758
|
6 |
Alper Sonmez, Teoman Dogru, Cemal Nuri Ercin, Halil Genc, Gurkan Celebi, Hasan Gurel, Serkan Tapan, Ali Fuat Cicek, Cem Barcin, Cem Haymana, Ali Kirik, Manfredi Rizzo. Betatrophin Levels Are Related to the Early Histological Findings in Nonalcoholic Fatty Liver Disease. Metabolites 2021; 11(7): 425 doi: 10.3390/metabo11070425
|
7 |
Norimasa Araki, Hirokazu Takahashi, Ayako Takamori, Yoichiro Kitajima, Hideyuki Hyogo, Yoshio Sumida, Saiyu Tanaka, Keizo Anzai, Shinichi Aishima, Kazuaki Chayama, Kazuma Fujimoto, Yuichiro Eguchi. Decrease in fasting insulin secretory function correlates with significant liver fibrosis in Japanese non‐alcoholic fatty liver disease patients. JGH Open 2020; 4(5): 929 doi: 10.1002/jgh3.12367
|
8 |
Hendra Susanto, Nan-Shan Liou, Bogi Pratomo, Tinny Endang Hernowati, Adeodatus Yuda Handaya, Hani Susianti, Moch. Bachtiar Budianto, Abdul Gofur, Eviana Norahmawati, Nia Lukita Ariani. Betatrophin expression in chronic hepatitis c patients: Does contribute to liver injury-linked metabolic syndrome and hepatocellular carcinoma development?. PROCEEDINGS OF THE 3RD INTERNATIONAL SEMINAR ON METALLURGY AND MATERIALS (ISMM2019): Exploring New Innovation in Metallurgy and Materials 2020; 2232: 030006 doi: 10.1063/5.0002469
|
9 |
Chenchen Wang, Ying Tong, Yankai Wen, Jie Cai, Han Guo, Lifeng Huang, Min Xu, Mingxuan Feng, Xiaosong Chen, Jianjun Zhang, Hailong Wu, Xiaoni Kong, Qiang Xia. Hepatocellular Carcinoma‐Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element‐Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth. Hepatology 2018; 68(5): 1833 doi: 10.1002/hep.30030
|
10 |
Beverly S Hong, Juan Liu, Jing Zheng, Weijian Ke, Zhimin Huang, Xuesi Wan, Xiaoying He, Haipeng Xiao, Yanbing Li. Angiopoietin‐like protein 8/betatrophin correlates with hepatocellular lipid content independent of insulin resistance in non‐alcoholic fatty liver disease patients. Journal of Diabetes Investigation 2018; 9(4): 952 doi: 10.1111/jdi.12792
|
11 |
Emanuela Orsi, Valeria Grancini, Stefano Menini, Alessio Aghemo, Giuseppe Pugliese. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?. Liver International 2017; 37(7): 950 doi: 10.1111/liv.13337
|
12 |
H Susanto, A Aulanni’am, C H Wang, D K Wuragil, A Y Handaya, M P Pertiwi, S A Rufiatin Nisa. The potential role of betatrophin in hepatocellular carcinoma and metabolic syndrome. Journal of Physics: Conference Series 2019; 1146: 012003 doi: 10.1088/1742-6596/1146/1/012003
|
13 |
G. Eser Karlidag, O. Arslan Solmaz. Are adropin, apelin, elabela, asprosin and betatrophin biomarkers for chronic hepatitis and staging of fibrosis?. Biotechnic & Histochemistry 2020; 95(2): 152 doi: 10.1080/10520295.2020.1714732
|
14 |
Hasan Gurel, Teoman Dogru. Betatrophin in nonalcoholic fatty liver disease. European Journal of Gastroenterology & Hepatology 2016; 28(4): 487 doi: 10.1097/MEG.0000000000000571
|
15 |
Mohamed Magdy Salama, Walaa Ahmed Kabiel, Silvia Shoukry Hana, Ghada Abdelrahman Mohamed. Correlation of serum betatrophin levels with disease severity and the emergence of insulin resistance in cirrhotic patients. Egyptian Liver Journal 2020; 10(1) doi: 10.1186/s43066-020-00039-7
|
16 |
Xin Su, Qinchen Xu, Zigan Li, Yidan Ren, Qinlian Jiao, Lina Wang, Yunshan Wang. Role of the angiopoietin-like protein family in the progression of NAFLD. Heliyon 2024; 10(7): e27739 doi: 10.1016/j.heliyon.2024.e27739
|